Skip to main content

Advertisement

Log in

Drug screening—beyond the bottleneck

  • Feature
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

Abstract

High-throughput screening still has a long way to go if it is to achieve its often-touted potential.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2: Big is beautiful.

References

  1. Kell, D. Screensavers: trends in high-throughput analysis. Trends Biotechnol. 17, 89–91 (1999).

    Article  CAS  Google Scholar 

  2. Archer, R. Towards the drug discovery factory. J. Assoc. Lab. Automat. 3, 4 (1998).

    Google Scholar 

  3. Frederickson, R. Macromolecular matchmaking: advances in two-hybrid and related technologies. Curr. Opin Biotechnol. 9, 90– 96 (1998).

    Article  CAS  Google Scholar 

  4. Young, K. et al. Identification of a calcium channel modulator using a high-throughput yeast two-hybrid screen. Nat. Biotechnol. 16, 946–950 (1998).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dove, A. Drug screening—beyond the bottleneck. Nat Biotechnol 17, 859–863 (1999). https://doi.org/10.1038/12845

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/12845

  • Springer Nature America, Inc.

This article is cited by

Navigation